SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-020579
Filing Date
2016-05-20
Accepted
2016-05-20 16:06:24
Documents
1
Period of Report
2016-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4078
  Complete submission text file 0000899243-16-020579.txt   5481
Mailing Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757
Business Address 113 CEDAR STREET SUITE 7 MILFORD MA 01757 508-473-5993
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SPRING BANK PHARMACEUTICALS, INC. 113 CEDAR STREET, SUITE S-7 MILFORD MA 01757
Business Address
Afdhal Nezam H. (Reporting) CIK: 0001664569 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 161666238